---
title: "Johnson & Johnson says nipocalimab approved in China"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/287185296.md"
description: "SHANGHAI, May 21 (Reuters) - Johnson & Johnson's ( JNJ ) nipocalimab has won approval in China, the U.S. drugmaker said on its WeChat social media account Thursday. (Reporting by Andrew Silver in Shanghai Editing by Tomasz Janowski)"
datetime: "2026-05-21T08:28:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/287185296.md)
  - [en](https://longbridge.com/en/news/287185296.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/287185296.md)
---

# Johnson & Johnson says nipocalimab approved in China

SHANGHAI, May 21 (Reuters) - Johnson & Johnson's ( JNJ ) nipocalimab has won approval in China, the U.S. drugmaker said on its WeChat social media account Thursday. (Reporting by Andrew Silver in Shanghai Editing by Tomasz Janowski)

### Related Stocks

- [JNJ.US](https://longbridge.com/en/quote/JNJ.US.md)

## Related News & Research

- [Fideuram Intesa Sanpaolo Private Banking S.P.A. Takes Position in Johnson & Johnson $JNJ](https://longbridge.com/en/news/287026863.md)
- [Know an investor on the hunt for the 'next big thing' in social media? We want to hear from you.](https://longbridge.com/en/news/287254640.md)
- [KENTUCKY SCHOOL DISTRICT AGREES TO DISMISS SOCIAL MEDIA ADDICTION CLAIMS AGAINST META - COURT FILING](https://longbridge.com/en/news/287257743.md)
- [BBBY Stock Alert: Why Bed Bath & Beyond Is Rising After a Social Media Post](https://longbridge.com/en/news/287117687.md)
- [Snapchat: Don't rush to buy this social media stock](https://longbridge.com/en/news/286681786.md)